Loading...
Cancer chemotherapy agents target intratumoral dendritic cells to potentiate antitumor immunity
Cytotoxic drugs capable of killing cancer cells in conjunction with targeted conversion of tumor resident, tolerogenic dendritic cells (DCs) into efficient antigen presenting cells (APCs) are highly complementary therapeutic routes to boost antitumor immunity. Our data suggest that the microtubule-d...
Na minha lista:
| Udgivet i: | Oncoimmunology |
|---|---|
| Main Authors: | , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Taylor & Francis
2014
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4292760/ https://ncbi.nlm.nih.gov/pubmed/25610745 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/21624011.2014.954460 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|